![Facilitating therapeutic antibody discovery with RenMab and RenLite humanized immunoglobulin mice.](https://img.swapcard.com/?u=https%3A%2F%2Fcdn-api.swapcard.com%2Fpublic%2Fimages%2F8b9108550efb4acaba55d76329eeacb0.png&q=0.8&m=fit&h=720)
![](https://img.swapcard.com/?u=https%3A%2F%2Fcdn-api.swapcard.com%2Fpublic%2Fimages%2F8b9108550efb4acaba55d76329eeacb0.png&q=0.8&m=crop&h=720)
Facilitating therapeutic antibody discovery with RenMab and RenLite humanized immunoglobulin mice.
Thursday, April 1, 2021 5:20 PM to 5:40 PM · 20 min. (Africa/Abidjan)
Antibodies
Bispecific & multispecifics
Presentation
Information
- RenMab mice carry fully human heavy chain and kappa light chain repertoire.
- RenLite mice share a common light chain and enable an efficient bi-specific antibody discovery process.
- Both RenMab and RenLite mice are proven to generate highly specific hits with high affinity.
- Robust immune response of RenMab and RenLite mice are comparable to wild type mice.
- Specific target gene Knockout of RenMab and RenLite mice enables robust immune response against challenging targets.
- Antibody discovery service with Beacon single B cell cloning speeds up the whole discovery process dramatically.